-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on LifeMD, Raises Price Target to $10

Benzinga·03/11/2026 10:51:53
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $9 to $10.